\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ shows\\ thyroid\\ enlargement\\ with\\ prominent\\ left\\ sided\\ nodules\\ as\\ well\\ as\\ bilateral\\ mastectomy\\.\ \(0\)\
\-\ cxr\\:\\ hypoinflation\\ of\\ lungs\\,\\ increased\\ pulmonary\\ vascular\\ markings\\ throughout\\ bilateral\\ lung\\ fields\\,\\ multiple\\ pulmonary\\ nodules\\ with\\ the\\ most\\ prominent\\ in\\ the\\ right\\ lower\\ lobe\\,\\ mild\\ cardiomegaly\\,\\ lack\\ of\\ breast\\ shadows\\ bilaterally\\,\\ fluid\\ withing\\ the\\ right\\ major\\ and\\ minor\\ fissure\\.\\ \ \(0\)\
\-\ ct\\ of\\ chest\\/abd\\/pelvis\\:\\ diffuse\\ thyroid\\ enlargement\\ with\\ nodule\\ present\\ in\\ the\\ left\\ lobe\\,\\ multiple\\ large\\ \\(\\>5mm\\)\\ pulmonary\\ nodules\\ throughout\\ both\\ lungs\\,\\ bilateral\\ myelolipomas\\ with\\ l\\ larger\\ than\\ r\\.\ \(0\)\
\-\ cowden\\'s\\ syndrome\ \(0\)\
\-\ cowden\\'s\\ syndrome\ \(0\)\
\-\ li\\-fraumeni\\ syndrome\ \(0\)\
\-\ peutz\\-jeghers\\ syndrome\ \(0\)\
\-\ brca1\\/2\ \(0\)\
\-\ ataxia\\-telangiectasia\\ syndrome\ \(0\)\
\-\ 48y\\/o\\ female\\ with\\ history\\ of\\ bilateral\\ breast\\ cancer\\ s\\/p\\ bilateral\\ mastectomy\\ who\\ is\\ currently\\ hospitalized\\ after\\ obtaining\\ bronchoscopy\\ to\\ evaluate\\ multiple\\ pulmonary\\ nodules\\.\ \(1\)\
\-\ patient\\ had\\ bilateral\\ mastectomy\\ prior\\ to\\ age\\ of\\ 50\\ indicating\\ a\\ likely\\ genetic\\ disorder\\ contributing\\ to\\ early\\ onset\\ breast\\ cancer\\ vs\\.\\ prophylactic\\ mastectomy\\'s\\.\\ \\ the\\ patient\\'s\\ thyroid\\ abnormalities\\ make\\ cowden\\'s\\ syndrome\\ the\\ most\\ likely\\ genetic\\ abnormality\\.\\ \\ the\\ multiple\\ pulmonary\\ nodules\\ as\\ well\\ as\\ myelolipomas\\ are\\ also\\ consistent\\ with\\ this\\ diagnosis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mastectomy\\:\\ 0\\.30983618071008795\ \(0\)\
\-\ nodules\\:\\ 0\\.2899349196173718\ \(0\)\
\-\ cowden\\:\\ 0\\.2883603950162937\ \(0\)\
\-\ syndrome\\:\\ 0\\.26398063983926867\ \(0\)\
\-\ bilateral\\:\\ 0\\.23533265553506513\ \(0\)\
\-\ myelolipomas\\:\\ 0\\.22304680282033804\ \(0\)\
\-\ pulmonary\\:\\ 0\\.22242316946255414\ \(0\)\
\-\ thyroid\\:\\ 0\\.17206050877302437\ \(0\)\
\-\ breast\\:\\ 0\\.15898773196265328\ \(0\)\
\-\ genetic\\:\\ 0\\.14395504840556328\ \(0\)\
\-\ multiple\\:\\ 0\\.14278429510611235\ \(0\)\
\-\ as\\:\\ 0\\.11727451737583662\ \(0\)\
\-\ prominent\\:\\ 0\\.11495542920558438\ \(0\)\
\-\ enlargement\\:\\ 0\\.11190009525003182\ \(0\)\
\-\ hypoinflation\\:\\ 0\\.10784288259374689\ \(0\)\
\-\ withing\\:\\ 0\\.10784288259374689\ \(0\)\
\-\ lungs\\:\\ 0\\.10771951360578111\ \(0\)\
\-\ throughout\\:\\ 0\\.10734596821583867\ \(0\)\
\-\ the\\:\\ 0\\.1019349878598977\ \(0\)\
\-\ cancer\\:\\ 0\\.09721959173153798\ \(0\)\
\-\ shadows\\:\\ 0\\.09378756393612261\ \(0\)\
\-\ hospitalized\\:\\ 0\\.0872522129350747\ \(0\)\
\-\ likely\\:\\ 0\\.08722200862037635\ \(0\)\
\-\ obtaining\\:\\ 0\\.08603284286040593\ \(0\)\
\-\ with\\:\\ 0\\.08574230009664546\ \(0\)\
\-\ contributing\\:\\ 0\\.08546414023959001\ \(0\)\
\-\ lobe\\:\\ 0\\.0843493797249855\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.07973224527849834\ \(0\)\
\-\ prophylactic\\:\\ 0\\.07973224527849834\ \(0\)\
\-\ 5mm\\:\\ 0\\.07776008735835689\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.076321077513541\ \(0\)\
\-\ most\\:\\ 0\\.07596193458707763\ \(0\)\
\-\ markings\\:\\ 0\\.0731968942774504\ \(0\)\
\-\ fields\\:\\ 0\\.07178513407527894\ \(0\)\
\-\ of\\:\\ 0\\.07140924973750228\ \(0\)\
\-\ fissure\\:\\ 0\\.07122473635730896\ \(0\)\
\-\ make\\:\\ 0\\.07086432654147515\ \(0\)\
\-\ well\\:\\ 0\\.07067448705526128\ \(0\)\
\-\ indicating\\:\\ 0\\.06904538844529019\ \(0\)\
\-\ minor\\:\\ 0\\.06859112644049878\ \(0\)\
\-\ larger\\:\\ 0\\.0653263922994595\ \(0\)\
\-\ major\\:\\ 0\\.06380671109177664\ \(0\)\
\-\ lack\\:\\ 0\\.062448529141224486\ \(0\)\
\-\ disorder\\:\\ 0\\.06173261078059116\ \(0\)\
\-\ cxr\\:\\ 0\\.058382696985195354\ \(0\)\
\-\ nodule\\:\\ 0\\.05760314406220999\ \(0\)\
\-\ evaluate\\:\\ 0\\.05674991446523341\ \(0\)\
\-\ currently\\:\\ 0\\.056061297911985185\ \(0\)\
\-\ vs\\:\\ 0\\.05567608207309176\ \(0\)\
\-\ to\\:\\ 0\\.05473452000817435\ \(0\)\
\-\ abnormality\\:\\ 0\\.05308414343417337\ \(0\)\
\-\ abnormalities\\:\\ 0\\.052864692043567967\ \(0\)\
\-\ early\\:\\ 0\\.05260622461877818\ \(0\)\
\-\ 50\\:\\ 0\\.05096735130965816\ \(0\)\
\-\ left\\:\\ 0\\.04979009397053904\ \(0\)\
\-\ bilaterally\\:\\ 0\\.04867235688228947\ \(0\)\
\-\ right\\:\\ 0\\.048391735075074944\ \(0\)\
\-\ vascular\\:\\ 0\\.04818023073352429\ \(0\)\
\-\ patient\\:\\ 0\\.04747341733779772\ \(0\)\
\-\ sided\\:\\ 0\\.04694441278551455\ \(0\)\
\-\ onset\\:\\ 0\\.04686248911784561\ \(0\)\
\-\ age\\:\\ 0\\.04581752469766364\ \(0\)\
\-\ diffuse\\:\\ 0\\.04576745143458453\ \(0\)\
\-\ lung\\:\\ 0\\.04439453702449087\ \(0\)\
\-\ shows\\:\\ 0\\.042832907450754694\ \(0\)\
\-\ fluid\\:\\ 0\\.04213700588124153\ \(0\)\
\-\ mild\\:\\ 0\\.04137024935080465\ \(0\)\
\-\ than\\:\\ 0\\.04137024935080465\ \(0\)\
\-\ who\\:\\ 0\\.041281955678178134\ \(0\)\
\-\ prior\\:\\ 0\\.040832400965092476\ \(0\)\
\-\ both\\:\\ 0\\.040697195454316895\ \(0\)\
\-\ physical\\:\\ 0\\.03957139522848624\ \(0\)\
\-\ consistent\\:\\ 0\\.03957139522848624\ \(0\)\
\-\ increased\\:\\ 0\\.03946407774278541\ \(0\)\
\-\ diagnosis\\:\\ 0\\.037832280225124824\ \(0\)\
\-\ present\\:\\ 0\\.037448374163228736\ \(0\)\
\-\ lower\\:\\ 0\\.03729282571357918\ \(0\)\
\-\ exam\\:\\ 0\\.036738134990846355\ \(0\)\
\-\ large\\:\\ 0\\.03656656936100198\ \(0\)\
\-\ had\\:\\ 0\\.03636128610768819\ \(0\)\
\-\ in\\:\\ 0\\.03631007787603547\ \(0\)\
\-\ after\\:\\ 0\\.035403762060763136\ \(0\)\
\-\ female\\:\\ 0\\.03521618393512206\ \(0\)\
\-\ also\\:\\ 0\\.0343276691307577\ \(0\)\
\-\ history\\:\\ 0\\.027882559431225265\ \(0\)\
\-\ ct\\:\\ 0\\.027784145850680748\ \(0\)\
\-\ are\\:\\ 0\\.027692565628675055\ \(0\)\
\-\ this\\:\\ 0\\.02507721938717909\ \(0\)\
\-\ is\\:\\ 0\\.019986050595720756\ \(0\)\
\-\ and\\:\\ 0\\.015080409753057899\ \(0\)\
